Literature DB >> 8599088

Heparin structure and interactions with basic fibroblast growth factor.

S Faham1, R E Hileman, J R Fromm, R J Linhardt, D C Rees.   

Abstract

Crystal structures of heparin-derived tetra- and hexasaccharides complexed with basic fibroblast growth factor (bFGF) were determined at resolutions of 1.9 and 2.2 angstroms, respectively. The heparin structure may be approximated as a helical polymer with a disaccharide rotation of 174 degrees and a translation of 8.6 angstroms along the helix axis. Both molecules bound similarly to a region of the bFGF surface containing residues asparagine-28, arginine-121, lysine-126, and glutamine-135, the hexasaccharide also interacted with an additional binding site formed by lysine-27, asparagine-102, and lysine-136. No significant conformational change in bFGF occurred upon heparin oligosaccharide binding, which suggests that heparin primarily serves to juxtapose components of the FGF signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599088     DOI: 10.1126/science.271.5252.1116

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  153 in total

1.  Mass spectral characterization of a protein-nucleic acid photocrosslink.

Authors:  M C Golden; K A Resing; B D Collins; M C Willis; T H Koch
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

2.  Structural interactions of fibroblast growth factor receptor with its ligands.

Authors:  D J Stauber; A D DiGabriele; W A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Crystal structure of a heparin- and integrin-binding segment of human fibronectin.

Authors:  A Sharma; J A Askari; M J Humphries; E Y Jones; D I Stuart
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  Six blind men and the elephant--the many faces of heparan sulfate.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Therapeutic Angiogenesis for Coronary Artery Disease.

Authors:  Tanveer A. Khan; Frank W. Sellke; Roger J. Laham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-02

Review 6.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.

Authors:  Alphonse I Arunkumar; Thallampuranam Krishnaswamy S Kumar; Karuppanan Muthusamy Kathir; Sampath Srisailam; Han-Min Wang; Philominathan Sagaya Theresa Leena; Ya-Hui Chi; Ho-Chz Chen; Chieh-Hsi Wu; Rong-Tsun Wu; Gu-Gang Chang; Ing-Ming Chiu; Chin Yu
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

8.  Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components.

Authors:  Julia P Steringer; Sascha Lange; Sabína Čujová; Radek Šachl; Chetan Poojari; Fabio Lolicato; Oliver Beutel; Hans-Michael Müller; Sebastian Unger; Ünal Coskun; Alf Honigmann; Ilpo Vattulainen; Martin Hof; Christian Freund; Walter Nickel
Journal:  Elife       Date:  2017-07-19       Impact factor: 8.140

9.  Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Authors:  Yuejie Zhao; Arunima Singh; Yongmei Xu; Chengli Zong; Fuming Zhang; Geert-Jan Boons; Jian Liu; Robert J Linhardt; Robert J Woods; I Jonathan Amster
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-23       Impact factor: 3.109

10.  Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.

Authors:  Po-Hung Hsieh; Yongmei Xu; David A Keire; Jian Liu
Journal:  Glycobiology       Date:  2014-04-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.